Alternate-Day Buprenorphine. Phase V - 6

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate buprenorphine blockade challenge.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Institute on Drug Abuse (NIDA)
• Collaborator: University of Vermont
• Treatments: Buprenorphine

Criteria

Please contact site for information.